Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO )

327.47 +1.53 (+0.47%)

Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Volume	691,290
Open	325.72
Bid (Size)	280.48 (1)
Ask (Size)	518.09 (1)
Prev. Close	325.94
Today's Range	325.72 - 334.10
52wk Range	262.12 - 387.99
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

November 21, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

October 31, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Performance

YTD	-0.16%	-0.16%
1 Month	-1.63%	-1.63%
3 Month	+0.27%	+0.27%
6 Month	+15.36%	+15.36%
1 Year	+2.03%	+2.03%

More News

Bio-Rad Reports Third-Quarter 2024 Financial Results

October 30, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

October 14, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Expert Ratings For Bio-Rad Laboratories

October 01, 2024

Via Benzinga

Triple-Witch Says, “Remember Me?”

September 20, 2024

Via Talk Markets

S&P 500 Shake-Up: New Entrants Driving Market Momentum

September 24, 2024

Via MarketBeat

Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.

September 13, 2024

Via The Motley Fool

Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?

September 09, 2024

Via Benzinga

Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping.

September 06, 2024

Via Investor's Business Daily

The Analyst Landscape: 4 Takes On Bio-Rad Laboratories

May 08, 2024

Via Benzinga

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

August 22, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

August 20, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Reports Second-Quarter 2024 Financial Results

August 01, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

July 17, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months

June 30, 2024

Via Benzinga

OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics

June 05, 2024

Via AB Newswire

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

June 05, 2024

Via TheNewswire.com

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

May 30, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

May 23, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024

May 07, 2024

Via InvestorPlace

Bio-Rad Reports First-Quarter 2024 Financial Results

May 07, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

May 01, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Announces Life Science Group Management Changes

April 26, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?

April 18, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.